NASDAQ:ISRG 22 June 2025 - 6 December 2025

Intuitive Surgical shares closed at $573.48 on November 28, 2025, giving the company a market cap near $203.6 billion. Institutional investors hold about 89% of the float, with recent filings showing modest increases from firms like Grantham Mayo and Schroder. The stock is up roughly 30% from October lows after strong earnings, but has underperformed the Nasdaq Composite in some November periods. Analyst consensus remains “Moderate Buy.”

Intuitive reported Q3 revenue of $2.51 billion, up 23% year-over-year, and adjusted EPS of $2.40, beating estimates. Global da Vinci surgery volume rose 19%, with 427 new robots placed and consumables sales hitting $1.52 billion. The company raised its 2025 outlook for procedure growth and gross margin. ISRG shares surged 17% after hours, trading in the mid-$500s on Oct. 22.

Intuitive Surgical shares jumped about 17% in after-hours trading Oct 21 after Q3 revenue hit $2.51 billion, up 23% year-over-year, and adjusted EPS reached $2.40, beating consensus. Global da Vinci procedures rose 19%, with 427 new robots placed. The company raised full-year 2025 procedure growth guidance to 17–17.5%.